{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:22:31Z","timestamp":1774437751694,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T00:00:00Z","timestamp":1558742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jfma.2019.05.021","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T02:09:42Z","timestamp":1560391782000},"page":"1560-1565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Progressive multifocal leukoencephalopathy in a 27-year-old lady with systemic lupus erythematosus \u2013 rheumatoid arthritis overlap syndrome"],"prefix":"10.1016","volume":"118","author":[{"given":"Chiao-Feng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Jen","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko-Jen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.jfma.2019.05.021_bib1","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section","volume":"80","author":"Berger","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jfma.2019.05.021_bib2","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1212\/WNL.0000000000004926","article-title":"The national incidence of PML in Sweden, 1988\u20132013","volume":"90","author":"Iacobaeus","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jfma.2019.05.021_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.rdc.2016.09.009","article-title":"The risk of progressive multifocal leukoencephalopathy in the biologic era: prevention and management","volume":"43","author":"Molloy","year":"2017","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"10.1016\/j.jfma.2019.05.021_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s13365-018-0615-7","article-title":"Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event","volume":"24","author":"Berger","year":"2018","journal-title":"J Neurovirol"},{"issue":"12","key":"10.1016\/j.jfma.2019.05.021_bib5","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.24966","article-title":"Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases","volume":"60","author":"Molloy","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.jfma.2019.05.021_bib6","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.34468","article-title":"Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies","volume":"64","author":"Molloy","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jfma.2019.05.021_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/0961203315622819","article-title":"Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: a systematic literature review","volume":"25","author":"Henegar","year":"2016","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.jfma.2019.05.021_bib8","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00415-016-8217-x","article-title":"Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases","volume":"263","author":"Maas","year":"2016","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.jfma.2019.05.021_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/ard.62.1.50","article-title":"Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature","volume":"62","author":"Warnatz","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.jfma.2019.05.021_bib10","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jfma.2019.05.021_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.jfma.2019.05.021_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.jfma.2019.05.021_bib13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ncl.2018.06.002","article-title":"Progressive multifocal leukoencephalopathy","volume":"36","author":"Grebenciucova","year":"2018","journal-title":"Neurol Clin"},{"issue":"5","key":"10.1016\/j.jfma.2019.05.021_bib14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0961203317691373","article-title":"Magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus: current state of the art and novel approaches","volume":"26","author":"Postal","year":"2017","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.jfma.2019.05.021_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"Tan","year":"2010","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.jfma.2019.05.021_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1474-4422(18)30040-1","article-title":"Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned","volume":"17","author":"Major","year":"2018","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.jfma.2019.05.021_bib17","first-page":"1896","article-title":"Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team","volume":"20","author":"Post","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"10.1016\/j.jfma.2019.05.021_bib18","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1468-1331.2011.03597.x","article-title":"Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis","volume":"19","author":"Sahraian","year":"2012","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.jfma.2019.05.021_bib19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1468-1331.2006.01362.x","article-title":"Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control","volume":"13","author":"Kuker","year":"2006","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.jfma.2019.05.021_bib20","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome","volume":"264","author":"Fischer","year":"2017","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.jfma.2019.05.021_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2008.07.006","article-title":"Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?","volume":"8","author":"Molloy","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.jfma.2019.05.021_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrrheum.2014.167","article-title":"Sorting out the risks in progressive multifocal leukoencephalopathy","volume":"11","author":"Calabrese","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.jfma.2019.05.021_bib23","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/art.22657","article-title":"Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease","volume":"56","author":"Calabrese","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jfma.2019.05.021_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1756285615602832","article-title":"Progressive multifocal leukoencephalopathy: current treatment options and future perspectives","volume":"8","author":"Pavlovic","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"issue":"10","key":"10.1016\/j.jfma.2019.05.021_bib25","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/acn3.114","article-title":"Outcome and survival of asymptomatic PML in natalizumab-treated MS patients","volume":"1","author":"Dong-Si","year":"2014","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664619301810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664619301810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T10:32:27Z","timestamp":1571394747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664619301810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0929664619301810"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2019.05.021","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive multifocal leukoencephalopathy in a 27-year-old lady with systemic lupus erythematosus \u2013 rheumatoid arthritis overlap syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2019.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}